These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24039107)

  • 1. Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
    Duarte-Rojo A; Budhraja V; Veldt BJ; Goldstein DD; Watt KD; Heimbach JK; McHutchison JG; Tillman HL; Poterucha JJ; Charlton MR
    Liver Transpl; 2013 Dec; 19(12):1311-7. PubMed ID: 24039107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.
    Graziadei IW; Zoller HM; Schloegl A; Nachbaur K; Pfeiffer KP; Mark W; Mikuz G; Pratschke J; Margreiter R; Vogel W
    Liver Transpl; 2012 Jun; 18(6):671-9. PubMed ID: 22298465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.
    Alborzi A; Hashempour T; Moayedi J; Musavi Z; Pouladfar G; Merat S
    Med Microbiol Immunol; 2017 Apr; 206(2):165-174. PubMed ID: 28214926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosing cholestatic hepatitis developing within one month after living donor liver transplantation for chronic hepatitis C-related cirrhosis: a case report.
    Murakami K; Kawagishi N; Ishida K; Sekiguchi S; Fujishima F; Sasano H; Ohuchi N
    Transplant Proc; 2014 Apr; 46(3):995-8. PubMed ID: 24767401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.
    Bitetto D; Fabris C; Falleti E; Fornasiere E; Avellini C; Cmet S; Cussigh A; Fontanini E; Pirisi M; Corradini SG; Merli M; Molinaro A; Toniutto P
    Transplantation; 2012 May; 93(10):1038-44. PubMed ID: 22495472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
    Firpi RJ; Dong H; Clark VC; Soldevila-Pico C; Morelli G; Cabrera R; Norkina O; Shuster JJ; Nelson DR; Liu C
    Liver Int; 2013 Jan; 33(1):72-8. PubMed ID: 23107586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
    Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
    Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
    Vukotic R; Conti F; Fagiuoli S; Morelli MC; Pasulo L; Colpani M; Foschi FG; Berardi S; Pianta P; Mangano M; Donato MF; Malinverno F; Monico S; Tamè M; Mazzella G; Belli LS; Viganò R; Carrai P; Burra P; Russo FP; Lenci I; Toniutto P; Merli M; Loiacono L; Iemmolo R; Degli Antoni AM; Romano A; Picciotto A; Rendina M; Andreone P;
    J Viral Hepat; 2017 Oct; 24(10):858-864. PubMed ID: 28370880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation.
    Sclair SN; Fiel MI; Wu HS; Doucette J; Aloman C; Schiano TD
    Clin Transplant; 2016 Jun; 30(6):722-30. PubMed ID: 27027987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma.
    Hori T; Onishi Y; Kamei H; Kurata N; Ishigami M; Ishizu Y; Ogura Y
    Am J Case Rep; 2016 Aug; 17():597-604. PubMed ID: 27545580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.
    Toniutto P; Bitetto D; Falleti E; Vadalà S; Cmet S; Cussigh A; Bulajic M; Zilli M; Fabris C
    Int J Surg; 2014 Oct; 12(10):1082-7. PubMed ID: 25219480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
    Neukam K; Nattermann J; Rallón N; Rivero A; Caruz A; Macías J; Vogel M; Benito J; Camacho A; Mira J; Schwarze-Zander C; Barreiro P; Martínez A; Rockstroh J; Soriano V; Pineda J
    HIV Med; 2011 Sep; 12(8):487-93. PubMed ID: 21375685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
    Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Liu SV; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML
    Medicine (Baltimore); 2018 Mar; 97(10):e9782. PubMed ID: 29517696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-28B polymorphism in hepatitis C and liver transplantation.
    Duarte-Rojo A; Deneke MG; Charlton MR
    Liver Transpl; 2013 Jan; 19(1):49-58. PubMed ID: 23008132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
    Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.
    Ackefors M; Nyström J; Wernerson A; Gjertsen H; Sönnerborg A; Weiland O
    J Viral Hepat; 2013 Nov; 20(11):770-8. PubMed ID: 24168256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.